Biggest News Aggregation in the World
📰 Sclerosis News

Page 8 - Sclerosis News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Sclerosis. Real-time updates on events, politics, business and more.

Detailed text transcripts for TV channel - BBCNEWS - 20210621:19:33:00

Should be reviewed. that never ever happened. so everybody that had a transfusion have had transfusions in the at—risk period. and really should be offered test for fc 28 hep c. which is never happened. do should be offered test for fc 28 hep c. which is never happened.- c. which is never happened. do you think our c. which is never happened. do you think your medical— c. which is never happened. do you think your medical prognosis - c. which is never happened. do you think your medical prog...
Transfusion Have Hepc Which Happenedc Which Blood Products

Detailed text transcripts for TV channel - BBCNEWS - 20210621:19:34:00

.atno . at no time during my operations did anybody say well actually, youre transfusion was in the at—risk period. we youre transfusion was in the at-risk period.— youre transfusion was in the at-risk period. youre transfusion was in the at-risk eriod. . , ., , at-risk period. we should test you for hep c- — at-risk period. we should test you for hep c- if _ at-risk period. we should test you for hep c. if that _ at-risk period. we should test you for hep c. if that is _ at-risk period. w...
Hepatitis C Hep C Risk Period Risk Eriod Sclerosis On Al Terrible Story

Signal detection theory can be used to better understand cognitive fatigue

Signal detection theory can be used to better understand cognitive fatigue A team of New Jersey researchers has shown that changes in perceptual certainty and response bias, two central metrics of signal detection theory (SDT), correlate with changes in cognitive fatigue. They also show that SDT measures change as a function of changes in brain activation. This finding was reported in Frontiers in Psychology on January 15, 2021, in the open access article "Using Signal Detection Theory to Bett...
Montclair State University New Jersey United States Joshua Sandry Glenn Wylie John Deluca

Kadmon Holdings, Inc.: Kadmon Doses First Patient in Open-Label Phase 2 Clinical Trial of Belumosudil in Systemic Sclerosis

(0) NEW YORK, NY / ACCESSWIRE / April 1, 2021 / Kadmon Holdings, Inc. (NASDAQ:KDMN) today announced that the first patient has been dosed in an open-label Phase 2 clinical trial of belumosudil, the Companys ROCK2 inhibitor, in patients with diffuse cutaneous systemic sclerosis (dcSSc), a chronic immune disorder characterized by fibrosis of the skin and internal organs. The Phase 2 study (KD025-215) will enroll up to 15 adults with dcSSc who will receive orally administered belumosudil 200 mg tw...
United States Harlanw Waksal Ellen Cavaleri Exchange Commission Kadmon Holdings Inc Drug Administration

Sex differences play roles in how patients respond to brain diseases

Sex differences play roles in how patients respond to brain diseases Men and women are impacted differently by brain diseases, like Alzheimers disease and Parkinsons disease. Researchers are urging their colleagues to remember those differences when researching treatments and cures. In APL Bioengineering, by AIP Publishing, University of Maryland scientists highlight a growing body of research suggesting sex differences play roles in how patients respond to brain diseases, as well as multiple s...
Alisa Morss Clyne Emily Henderson Vascular Kinetics Laboratory University Of Maryland Vascular Kinetics Alzheimer 39s Disease

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

New molecule passes toxicology testing to treat multiple sclerosis

Brazilian researchers who study a native venomous fish have confirmed a route to drug development for the treatment of chronic inflammatory diseases such as multiple sclerosis and asthma.
Lopes Ferreira Emily Henderson Dissemination Centers Ridcs Brazilian Multiple Sclerosis Association Paulo Research Foundation Butantan Institute Special Laboratory For Applied Toxinology

Researchers confirm new drug development route for treating multiple sclerosis, asthma

Researchers confirm new drug development route for treating multiple sclerosis, asthma Brazilian researchers who study a native venomous fish have confirmed a route to drug development for the treatment of chronic inflammatory diseases such as multiple sclerosis and asthma. The venomous toadfish Thalassophryne nattereri contains a peptide (TnP) with anti-inflammatory and anti-allergic potential. Confirmation of this potential has now come via the zebrafish Danio rerio, a popular aquarium specie...
Lopes Ferreira Emily Henderson Dissemination Centers Ridcs Brazilian Multiple Sclerosis Association Paulo Research Foundation Butantan Institute Special Laboratory For Applied Toxinology

Researchers identify the trigger of key cellular change in amyotrophic lateral sclerosis

Researchers identify the trigger of key cellular change in amyotrophic lateral sclerosis Scientists at the Francis Crick Institute and UCL have identified the trigger of a key cellular change in amyotrophic lateral sclerosis (ALS), a type of motor neurons disease. The findings could help develop new treatments for many neurological diseases with the same change, including Parkinsons and Alzheimers. When the nervous system is injured, diseased or infected, star-shaped cells, called astrocytes, u...
Oliver Ziff Rickie Patani Emily Henderson National Hospital For Neurology Queen Square Institute Of Neurology Group Leader

Experts highlight need to support people with disabilities in post-pandemic workplace

Experts highlight need to support people with disabilities in post-pandemic workplace COVID-19 has wrought havoc on the global economy and the worlds public health systems. People with disabilities are more likely to suffer severe cases of the disease. Experts advocate in this special issue of the Journal of Vocational Rehabilitation that vocational rehabilitation across the major life phases of health, work, and education must focus on access to technology and home-based employment and ensure...
United States Phillipd Rumrill Jr Lynnc Koch Davidr Strauser Emily Henderson University Of Illinois

Scientists identify new compound that reverses ALS neuron damage

Northwestern University scientists have identified the first compound that eliminates the ongoing degeneration of upper motor neurons that become diseased and are a key contributor to ALS (amyotrophic lateral sclerosis), a swift and fatal neurodegenerative disease that paralyzes its victims.
Hande Ozdinler Patrickg Ryan Richardb Silverman Emily Henderson Northwestern University Northwestern University Feinberg School Of Medicine

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science